Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News SCAI 2025

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

L.A. McKeown

May 07, 2025

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Daily News

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Yael L. Maxwell

February 15, 2023

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

Could a Coronary Calcium Test Rule Out CAD in Chest Pain?

Michael O'Riordan

October 21, 2021

News Daily News

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

Yael L. Maxwell

January 26, 2021

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Conference News EuroPCR 2019

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

L.A. McKeown

June 07, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2016

Caitlin E. Cox

October 29, 2016

News Daily News

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Todd Neale

February 07, 2016

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

Advertisement

What’s Going to Be Hot at TCT 2025

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

New Biomarker-Based Risk Score Performs Well in ACS

Could a Coronary Calcium Test Rule Out CAD in Chest Pain?

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

TCTMD’s Top 10 Most Popular Stories for February 2018

TCTMD’s Top 10 Most Popular Stories for October 2016

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Event Rates Often Overestimated in Cardiovascular Trials

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content